1p36 deletion syndrome affects an estimated 1 in 5,000 to 1 in 10,000 live births, making it one of the most common chromosome deletion syndromes. That translates to roughly 400 to 800 babies born with the condition each year in the United States alone. While it’s considered rare in absolute terms, it’s among the most frequently seen deletions that geneticists diagnose.
How the Prevalence Estimate Varies
The commonly cited range of 1 in 5,000 to 1 in 10,000 comes from studies of the American population conducted over the past two decades. However, more recent data suggests the true number may depend on how thoroughly a region tests for it. A French study that tracked new diagnoses between 2012 and 2016 found a rate closer to 1 in 18,000 live births in their region, with an average of about 10 new cases diagnosed nationally per year. The researchers noted this was lower than the classic estimates, likely because not every case gets identified, especially milder ones where the missing piece of chromosome 1 is smaller.
This gap highlights an important reality: 1p36 deletion syndrome is almost certainly underdiagnosed. Children with smaller deletions can have subtler symptoms, and without genetic testing, they may receive other diagnoses or no specific diagnosis at all. As chromosomal microarray testing becomes more routine in evaluating developmental delays, the number of confirmed cases continues to grow.
What Causes It
The syndrome occurs when a piece of genetic material is missing from the short arm (the “p” side) of chromosome 1, near the tip at position 36. The size of the missing segment varies from person to person, and this is a big part of why symptoms range from moderate to severe. Larger deletions tend to affect more genes and produce more medical complications.
The vast majority of cases happen spontaneously. The deletion is not inherited from a parent but instead occurs as a random event during the formation of reproductive cells or very early in embryonic development. This means most parents of an affected child have normal chromosomes themselves and had no way to predict or prevent it.
How It’s Diagnosed
Most cases are identified after birth when a baby shows a combination of distinctive facial features, low muscle tone, and developmental concerns. The definitive test is chromosomal microarray analysis, which can detect the deletion and measure its size with precision. This has largely replaced older methods that could miss smaller deletions.
Prenatal detection is possible but less common. In one study of prenatally identified cases, most were flagged because of abnormal ultrasound findings like heart malformations or restricted fetal growth. One case was caught through cell-free DNA screening, a blood test offered during pregnancy. When prenatal signs raise suspicion, microarray testing on an amniocentesis sample can confirm the diagnosis.
Features and Health Challenges
1p36 deletion syndrome affects multiple body systems, and most children share a core set of features, though the severity varies considerably. Developmental delay and intellectual disability are nearly universal. Children typically reach milestones like sitting, standing, and speaking much later than expected, and many require lifelong support.
Seizures are one of the most significant neurological concerns. In a study of 91 individuals, 58% developed epilepsy, with the first seizure occurring at a median age of about 2.75 months. Around 22% of those studied developed infantile spasms, a specific type of seizure pattern that typically appeared by 5 months of age. About 21% went on to develop difficult-to-control epilepsy with multiple seizure types.
Structural brain abnormalities are found in about 88% of individuals. Vision problems affect roughly 52%, and hearing loss occurs in about 47%.
Heart Involvement
Heart problems are common and often require early medical attention. In a large review, about 42% of individuals with 1p36 deletion syndrome had some form of cardiovascular involvement. The most frequent findings were holes between the heart chambers (septal defects), accounting for 36% of all cardiac abnormalities identified. Of these, about two-thirds were holes between the lower chambers and one-third between the upper chambers.
Beyond structural defects present at birth, the syndrome also carries a notable risk of cardiomyopathy, a condition where the heart muscle itself is weakened. Cardiomyopathy made up about 15% of all cardiac findings, and a specific form where the heart muscle has a spongy texture was the most common type. This is an important distinction because cardiomyopathy can develop later in childhood, meaning heart monitoring needs to continue even if early screenings look normal.
Other features seen at varying rates include skeletal abnormalities (41%), differences in the external genitalia (25%), and kidney abnormalities (22%). Short stature is also common, with growth often falling behind in early childhood.
Why Severity Varies So Much
Not everyone with 1p36 deletion syndrome is affected to the same degree, and the primary reason is the size and location of the missing genetic material. Researchers have identified specific genes within the 1p36 region that appear responsible for particular symptoms. One gene is linked to developmental delay, seizures, and heart defects. Another is associated with short stature, brain abnormalities, vision and hearing problems, and cardiomyopathy.
When a deletion is large enough to remove both of these critical regions, the clinical picture tends to be more severe, with higher rates of each individual symptom. Smaller deletions that affect only one region may produce a milder presentation. This is why two children with the same syndrome can look very different from each other, and why genetic testing that maps the exact boundaries of the deletion is so valuable for anticipating which health issues to monitor.